
|Articles|December 9, 2015
ICON Chooses goBalto for Study Startup
ICON is using Activate for all global studies, which span more than 50 countries.
Advertisement
goBalto announced that ICON has chosen goBalto’s flagship product Activate to bolster ICON’s clinical study startup process on a worldwide basis. ICON is using Activate for all global studies, which span more than 50 countries. ICON has already integrated Activate with its CTMS and data warehouse, and has plans to integrate with its eTMF system.
Read the full
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
2
ACT Brief: Decentralized Innovation Faces Reality, RWE Finds Its Lane, and Clinical Ops Reset for 2026
3
ESG as a Quality System: Practical Steps to Embed Sustainability Into Vendor Oversight
4
Operational and Governance Barriers to Regulatory-Grade RWE
5



